These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
832 related articles for article (PubMed ID: 23862765)
1. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours. Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
5. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
7. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach. Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437 [TBL] [Abstract][Full Text] [Related]
8. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Miettinen M; Sobin LH; Sarlomo-Rikala M Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Lasota J; Miettinen M Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355 [TBL] [Abstract][Full Text] [Related]
12. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors]. Tang M; Li DQ Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502 [TBL] [Abstract][Full Text] [Related]
13. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
14. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
15. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B; Hornick JL; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564 [TBL] [Abstract][Full Text] [Related]
17. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors]. Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362 [TBL] [Abstract][Full Text] [Related]
18. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features and immunophenotypes of CD117-negative gastrointestinal stromal tumor]. Shi JL; Chang XY; Chen J Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):310-4. PubMed ID: 21756824 [TBL] [Abstract][Full Text] [Related]
20. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)]. He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]